In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 adopted for its implementation, as amended and supplemented, the Competition Council makes available to the public the ‘operation summary’ below, containing the information provided by the parties.<\/p>\n
This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not prejudge the Competition Council’s position on the proposed operation.<\/p>\n
The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 adopted for the implementation of Law No. 104-12 on freedom of prices and competition as amended and supplemented.<\/p>\n
Names of companies and groups involved:<\/strong><\/p>\n Nature of the operation:<\/strong><\/p>\n Economic sectors concerned:<\/strong><\/p>\n Deadline for interested third parties to submit their observations:<\/strong><\/p>\n NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES<\/strong><\/p>\n The Competition Council has received notification of an economic concentration operation concerning the joint takeover by ‘Tettucio Pharma Holdings SAS’ and ‘Compagnie Financi\u00e8re Holding Atlas SA’ of the company ‘Corporate Investment Holding SA’.<\/p>\n ‘Tettucio Pharma Holdings SAS’ is a Moroccan simplified joint-stock company with its registered office at 46, Boulevard Zerktouni, 3rd<\/sup> floor, Apt No.6, Casablanca, registered with the Casablanca Trade Register under number 652203. ‘Tettucio Pharma Holdings SAS’ is an investment company whose purpose is to acquire stakes in companies.<\/p>\n ‘Compagnie Financi\u00e8re Holding Atlas SA’ is a Moroccan public limited company with a board of directors, with its registered office at 88, Rue El Marrakchi, Hippodrome District, Casablanca, registered with the Casablanca Trade Register under number 181559. It operates in the fields of investment banking, stockbroking, asset management, and real estate.<\/p>\n ‘Corporate Investment Holding SA’ is a Moroccan public limited company with a board of directors, with its registered office at Rue d’Amyot d’Inville, Arsalane Ain Borja District, Casablanca, registered with the Casablanca Trade Register under number 189919. ‘Corporate Investment Holding SA’ owns the following companies: ‘Polym\u00e9dic’ engaged in the production and distribution of drugs, ‘Pharmena’ engaged in the distribution of dietary supplements, ‘Fonci\u00e8re Amyot’, which holds real estate assets of the ‘CIH’ group, and ‘Promaceutique’ engaged in consulting and information services and promotion of health or cosmetic products for the ‘Corporate Investment Holding SA’ group.<\/p>\n <\/p>\n Done in Rabat on May 22, 2025.<\/p>\n","protected":false},"excerpt":{"rendered":" In accordance with Article 13 of Law No. 104-12 on freedom of prices and competition and Article 10 of Decree No. 2-14-652 adopted for its implementation, as amended and supplemented, the Competition Council makes available to the public the ‘operation summary’ below, containing the information provided by the parties. This information has been prepared by the notifying parties, who are solely responsible. Any inaccurate or distorted information contained therein does not prejudge the Competition Council’s position on the proposed operation. The publication of this press release does not attest to the completeness of the file provided for in Article 9 of Decree No. 2-14-652 adopted for the implementation of Law No. 104-12 on freedom of prices and competition as amended and supplemented. Names of companies and groups involved: The acquirers: ‘Tettucio Pharma Holdings SAS’ and ‘Compagnie Financi\u00e8re Holding Atlas SA’; The target: ‘Corporate Investment Holding SA’. Nature of the operation: Joint takeover. Economic sectors concerned: Markets for the production and marketing of drugs and dietary supplements. Deadline for interested third parties to submit their observations: 10 days from the date of publication of this press release, i.e. June 2, 2025. NON-CONFIDENTIAL SUMMARY OF THE OPERATION PROVIDED BY THE PARTIES The Competition Council has received notification of an economic concentration operation concerning the joint takeover by ‘Tettucio Pharma Holdings SAS’ and ‘Compagnie Financi\u00e8re Holding Atlas SA’ of the company ‘Corporate Investment Holding SA’. ‘Tettucio Pharma Holdings SAS’ is a Moroccan simplified joint-stock company with its registered office at 46, Boulevard Zerktouni, 3rd floor, Apt No.6, Casablanca, registered with the Casablanca Trade Register under number 652203. ‘Tettucio Pharma Holdings SAS’ is an investment company whose purpose is to acquire stakes in companies. ‘Compagnie Financi\u00e8re Holding Atlas SA’ is a Moroccan public limited company with a board of directors, with its registered office at 88, Rue El Marrakchi, Hippodrome District, Casablanca, registered with the Casablanca Trade Register under number 181559. It operates in the fields of investment banking, stockbroking, asset management, and real estate. ‘Corporate Investment Holding SA’ is a Moroccan public limited company with a board of directors, with its registered office at Rue d’Amyot d’Inville, Arsalane Ain Borja District, Casablanca, registered with the Casablanca Trade Register under number 189919. ‘Corporate Investment Holding SA’ owns the following companies: ‘Polym\u00e9dic’ engaged in the production and distribution of drugs, ‘Pharmena’ engaged in the distribution of dietary supplements, ‘Fonci\u00e8re Amyot’, which holds real estate assets of the ‘CIH’ group, and ‘Promaceutique’ engaged in consulting and information services and promotion of health or cosmetic products for the ‘Corporate Investment Holding SA’ group. Done in Rabat on May 22, 2025.<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[352],"tags":[],"class_list":["post-39540","post","type-post","status-publish","format-standard","hentry","category-press-releases"],"acf":[],"yoast_head":"\n\n
\n
\n
\n